Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
about
Viral vectors for neurotrophic factor delivery: a gene therapy approach for neurodegenerative diseases of the CNSGene delivery with viral vectors for cerebrovascular diseases.Gene therapy progress and prospects: Duchenne muscular dystrophy.Clinical applications involving CNS gene transfer.Transgene expression in the striatum following intracerebral injections of DNA nanoparticles encoding for human glial cell line-derived neurotrophic factor.Gene therapy for Parkinson's disease using recombinant adeno-associated viral vectors.GDNF and addiction.GDNF--a potential target to treat addiction.Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.Development of inducible EIAV-based lentiviral vector packaging and producer cell lines.A replication competent lentivirus (RCL) assay for equine infectious anaemia virus (EIAV)-based lentiviral vectors.Comparative analysis of HIV-1-based lentiviral vectors bearing lyssavirus glycoproteins for neuronal gene transfer.Cell transplantation and gene therapy in Parkinson's disease.Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE).In vivo methods for acute modulation of gene expression in the central nervous systemGlycomic and Proteomic Changes in Aging Brain Nigrostriatal Pathway
P2860
Q33894621-ADED73E2-1790-43BF-9804-7AF6DADB0371Q33917592-09DECF12-5FC1-4E10-A52E-EEDEFC63F0F1Q34576814-024B6001-60A7-4A92-9BF3-3A7447C8BB6DQ35899850-19CFA68D-55F7-4CB4-BA30-894A5AFE7F82Q36128982-570223A8-07BD-43DB-B49E-F81DABADB400Q36150495-4D85BD85-8432-4B7D-93D7-999EC317C0DBQ36414656-729B4384-8F96-4EBC-8667-253C24193A4DQ36928841-049F4EDF-36DB-4D43-9967-8A111C1739CBQ37416147-4D8A6552-5C27-4F9F-B7E7-9CF831DE78C2Q37791489-4737EA25-0AB0-433B-8AA9-0B77E8AE9B0FQ39877047-990A416A-423B-4A1B-8AB2-55A5CE4698A6Q40364996-1854AF07-4586-402A-A376-BCF78F5FBF67Q43183949-D95C32B9-23D5-4E98-ABF9-53763AEA80C3Q44297524-67602B3B-71E4-4990-BDB9-67F1B671F3A3Q45879104-C64325CB-E2E8-4D3A-9C30-F36EAE51A069Q57020987-87C05E97-99E3-4C68-97E7-94DDD0E28E05Q57829929-ED094AC9-AC56-4F08-BFB4-C3E588C4FBCC
P2860
Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
@en
type
label
Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
@en
prefLabel
Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
@en
P2093
P1433
P1476
Neuroprotection in a rat Parkinson model by GDNF gene therapy using EIAV vector.
@en
P2093
Denise Day
Kyriacos A Mitrophanous
Liang-Fong Wong
Mimoun Azzouz
Nicholas D Mazarakis
Robert D Barber
Scott Ralph
Susan M Kingsman
Zoe Askham
P304
P356
10.1097/00001756-200404290-00011
P577
2004-04-01T00:00:00Z